DM

Deerfield Management Portfolio holdings

AUM $6.52B
1-Year Est. Return 13.67%
This Quarter Est. Return
1 Year Est. Return
+13.67%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.01B
AUM Growth
+$259M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$88.1M
2
+$62.8M
3
+$39.4M
4
LRMR icon
Larimar Therapeutics
LRMR
+$35.6M
5
PHAT icon
Phathom Pharmaceuticals
PHAT
+$26.8M

Top Sells

1
+$85.2M
2
+$69.6M
3
+$55M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$53.1M
5
DAWN icon
Day One Biopharmaceuticals
DAWN
+$49.7M

Sector Composition

1 Healthcare 53.67%
2 Financials 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$36.1M 0.72%
464,000
-114,800
27
$34.8M 0.69%
359,765
+160,765
28
$34.6M 0.69%
1,358,000
+500,885
29
$32.5M 0.65%
3,081,000
+608,000
30
$30.3M 0.6%
2,219,128
-407,872
31
$26.8M 0.53%
+2,414,897
32
$26M 0.52%
+1,743,628
33
$25.8M 0.51%
+750,000
34
$24.7M 0.49%
75,000
-92,000
35
$23.3M 0.46%
+816,994
36
$22.7M 0.45%
1,324,214
37
$22.1M 0.44%
2,532,792
+112,245
38
$20.7M 0.41%
960,484
39
$20.7M 0.41%
1,032,000
-2,480,123
40
$20.4M 0.41%
+1,454,279
41
$18M 0.36%
+2,054,794
42
$17.7M 0.35%
235,934
+24,723
43
$15.9M 0.32%
2,677,500
44
$15.6M 0.31%
1,600,000
45
$15.6M 0.31%
3,360,052
-23,047
46
$15.5M 0.31%
292,000
47
$14.9M 0.3%
514,348
-56,818
48
$13.9M 0.28%
+870,000
49
$12.5M 0.25%
716,538
50
$12.2M 0.24%
+175,000
1
2
3 4 5